The Effect of Susceptibility of Gadolinium Contrast Media on Diffusion-weighted Imaging and the Apparent Diffusion Coefficient

Academic Radiology

Volumn 15, Issue 7, 2008, Pages 867-872

  Ogura, Akio ^a,b   Hayakawa, Katsumi ^a   Miyati, Tosiaki ^b   Maeda, Fumie ^a  

^a KYOTO CITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

apparent diffusion coefficient; Diffusion weighted image; gadolinium contrast medium; susceptibility

Indexed keywords

GADOLINIUM PENTETATE;

ARTICLE; BRAIN METASTASIS; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; HUMAN; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MENINGIOMA; PHANTOMS, IMAGING;

EID: 47749095030     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2007.12.020     Document Type: Article

References (17)

1. Takahara T., Imai Y., Yamashita T., et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 22 (2004) 275-282
2. Nasu K., Kuroki Y., Nawano S., et al. Hepatic metastases: diffusion weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239 (2006) 122-130
3. Moteki T., and Ishizuka H. Diffusion-weighted EPI of cystic ovarian lesions: evaluation of cystic contents using apparent diffusion coefficients. J Magn Reson Imaging 12 (2000) 1014-1019
4. Moteki T., Horikoshi H., and Endo K. Diffusion coefficient and signal intensity in endometrial and other pelvic cysts. Magn Reson Imaging 20 (2002) 463-470
5. Sato C., Naganawa S., Nakamura T., et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 21 (2005) 258-262
6. Shimofusa R., Fujimoto H., Akamoto H., et al. Diffusion-weighted imaging of prostate cancer. J Compt Assist Tomogr 29 (2005) 149-153
7. Naganawa S., Sato C., Kumada H., et al. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15 (2005) 71-78
8. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
9. Naganawa S., Kawai H., Fukatsu H., et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 4 (2005) 175-186
10. Pickles MD, Gibbs P, Sreenivas M, et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3T. J Magn Reson Imaging 20006; 23:130-134.
11. Koinuma M., Ohashi I., Hanafusa K., et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 22 (2005) 80-85
12. Sun X.J., Quan X.Y., Huang F.H., et al. Quantitative evaluation of diffusion-weighted magnetic resonance imaging of focal hepatic lesions. World J Gastroenterol 11 (2005) 6535-6537
13. Yoshikawa T., Kawamitsu H., Mitchell D.G., et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 187 (2006) 522-1530
14. Dose M.D., Zhong J., and Gore J.C. In vivo measurement of ADC change due to intravascular susceptibility variation. Magn Reson Med 41 (1999) 236-240
15. Zhong J., Kennan R.P., Fulbringht R.K., et al. Quantification of intravascular and extravascular contributions to bold effects induced by alteration in oxygenation or intravascular contrast agents. Magn Reson Med 40 (1998) 526-536
16. Yamada K., Kubota H., Kizu O., et al. Effect of intravenous gadolinium-DTPA on diffusion weighted images. Stroke 33 (2002) 1799-1802
17. Chen G., Jespersen S.N., Pedersen M., et al. Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging 23 (2005) 685-689